• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DIL
Click for more information
0.00% $7.03

Diligent Corporation (NS)

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DIL
Ann: Diligent Corporation (NS) (“DIL”) – Delisting Update 		14/04/16 0 335
14/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  335 
DIL
Ann: SSH Notice - Morgan Stanley and its subsidiaries 		14/04/16 0 369
14/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  369 
DIL
Ann: SSH Notice - Credit Suisse Holdings (Australia) Limited 		14/04/16 0 332
14/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  332 
DIL
Ann: SSH Notice - UBS Group AG and its related bodies corporate 		14/04/16 0 421
14/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  421 
DIL
Ann: SSH: DIL: SSH Notice - UBS Group AG and its related bodies corporate 		14/04/16 0 322
14/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  322 
DIL
Ann: Disclosure of Directors/Senior Managers Relevant Interest 		13/04/16 0 301
13/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  301 
DIL
Ann: Form 10-K/A 		13/04/16 0 300
13/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  300 
DIL
Ann: Diligent provides update on conditions to the Merger 		13/04/16 0 270
13/04/16 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  270 

See All Discussions arrow Created with Sketch.

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The winners & losers on market if negative gearing were gone Removing negative gearing would likely cause a seismic shift in investor behaviour. If that advantage were taken away, more investors might start eyeing the stock market...
5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core Strickland Metals Ltd has found an extensive zone of high-grade gold and base metals mineralisation at its Rogozna project
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.